Navigation Links
Ingenious Med's IM Quality Measures(TM) Delivers Insight About Hospitalist Performance
Date:6/10/2008

rtant to that agenda. It's also important that hospitalists have the opportunity to get the same 1.5% PQRI reporting bonus as other specialties. It was nice to be able to call on Ingenious Med and get the data to make our case."

But the value of IM Quality Measures(TM) extends beyond the PQRI. For example, Scottsdale Inpatient Specialists in Scottsdale, Arizona, a rapidly expanding practice, anticipates that documenting outstanding quality measures will lead to enhanced reimbursement by non-government payors.

"We started using IM Quality Measures(TM) because it is the right thing to do from a quality standpoint," explained Scottsdale Inpatient Specialists Medical Director Bruce Waldon, MD, FACP. "A reminder on IM Practice Manager(TM) is a safety net and helps us make sure we do not miss something. Our goal has been to have 100% compliance with the medical core measures and we've hit 100% on all of them since November of 2007."

Waldon thinks the focus on quality will result in enhanced reimbursement from private payors.

"It should help us in the long run," he said. "If we can demonstrate that our outcomes are better and that we reduced re-admissions, we can negotiate better terms with payors. It allows us to say, 'we're saving you money by doing things right and we should get paid for doing the right things.'"

About Ingenious Med: Ingenious Med was founded in 1999 by a group of practicing hospitalist leaders and has a customer base comprising thousands of users in over 500 facilities across the United States. Ingenious Med's flagship product, IM Practice Manager(TM) is an Internet-based application that enables inpatient physicians to capture charges, improve their quality of care, and communicate digitally with their peers and administrators. In addition, the program aggregates management data separately from the hospital information system, so individual physician and total department performance can be accurately evaluated. Natio
'/>"/>

SOURCE Ingenious Med
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Dr. Steve Liu, CEO of Ingenious Med, Joins Benchmarks Committee at SHM
2. Ingenious Med Reports Record Sales and Client Expansions in 2007
3. Ingenious Med Forms Multiple Billing Company Partnerships to Market Inpatient Practice Management Solutions
4. Cardiovascular Meds May Be Beneficial in Alzheimers Disease, According to MedPredict Report
5. Medsn to Become Indegene Pharmaceutical Solutions, Inc.: Change Signifies the Success of Its Innovative Global Services Model
6. Many Americans Share Prescription Meds
7. Breast-Feeding While on Seizure Meds Doesnt Harm Babies
8. Webcast Alert: EP MedSystems Announces EP MedSystems Fourth Quarter 2007 Earnings Conference Call Webcast
9. MedStar Health Unveils Rx for Success Program at Vivien T. Thomas Medical Arts Academy
10. Pregnant Women With Asthma Should Stay on Low Dose of Meds
11. Geriatrician Care Guards Against Risk of Inappropriate Meds
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... YORK April 17, 2014 EcoHealth Alliance, a ... health issues, published a comprehensive review today examining the ... Marburg virus. The review calls for improved global surveillance ... as the recent outbreak of Ebola in West Africa ... the countries of Guinea and Liberia. According to ...
(Date:4/17/2014)... Population Council scientists and their partners have found that ... prevent the transmission of multiple sexually transmitted infections (STIs) ... herpes simplex virus 2 (HSV-2), and human papillomavirus (HPV). ... the gel is effective against multiple strains of HIV, ... against all three viruses of at least eight hours ...
(Date:4/17/2014)... 40 years away from a food shortage that will ... a top scientist at the U.S. Agency for International ... production will be limited on a global scale by ... Fred Davies, senior science advisor for the agency,s bureau ... destabilizing by 2050 as energy issues are today.", Davies, ...
(Date:4/17/2014)... University Belfast,s Vice-Chancellor, Professor Patrick Johnston, whose work has ... as a Fellow of the European Academy of Cancer ... an independent advisory body of highly distinguished oncologists and ... suffering caused by cancer in Europe. , Professor Johnston, ... Ireland move from the bottom of the UK league ...
(Date:4/16/2014)... April 15, 2014 The Translational Genomics Research ... their annual Founders Dinner for their support of TGen,s ... took place March 28 in Scottsdale. , Catherine Ivy, ... Foundation, received TGen,s John S. McCain Leadership Award, named ...
Breaking Medicine News(10 mins):Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Animal study provides first evidence that gel can prevent multiple virus transmission in vagina/rectum 2Health News:Food shortages could be most critical world issue by mid-century 2Health News:TGen honors Catherine Ivy and Craig Jackson with Leadership; Collaborative Spirit awards 2
... Southern California Celebrity Gala, COSTA MESA, Calif., Aug. ... a major fundraiser to benefit,families affected by autism with ... McCarthy and Armstrong host the celebrity-packed evening Ante ... in Dana Point, California on,Friday, October 3, 2008. Joining ...
... MIAMI, Aug. 5 The National Parkinson,Foundation (NPF) ... programs,dedicated to Parkinson,s disease research, care and outreach ... network of 44,centers of excellence, 10 comprehensive care ... reaches more than 50,000 patients with,Parkinson,s disease and ...
... for Executive Communication, Training and Disaster ... ... (OTC,BB: TNXI), a leading IP solutions provider offering telepresence and VoIP,services ... been selected by St. Vincent Catholic Medical,Centers of New York for ...
... The Procter & Gamble,Company (NYSE: PG ) announced net ... to $21.3 billion and nine percent net sales growth for ... percent for both,the quarter and the fiscal year. This marks ... top-line growth at or above the,company,s targets., Diluted net ...
... Toronto Stock Exchange Symbol: CYT, MONTREAL, Aug. 5 ... products to treat cardiac,arrhythmias, today announced financial results for ... Third Quarter Financial and Operational Highlights: - ... a 12.0% increase over comparable ...
... NANJING, China, Aug. 5 /Xinhua-PRNewswire/ -- Simcere Pharmaceutical,Group (NYSE: ... branded generic,pharmaceuticals and manufacturer of the patented anti-cancer biotech,product ... the,quarter ended June 30, 2008., Highlights ... for the second quarter, representing ...
Cached Medicine News:Health News:Jenny McCarthy and Lance Armstrong Top Celebrity List to Raise Funds for Autism 2Health News:National Parkinson Foundation Awards $3.7 Million in Grants 2Health News:St. Vincent's Catholic Medical Centers of New York Select Telanetix Telepresence Solution 2Health News:St. Vincent's Catholic Medical Centers of New York Select Telanetix Telepresence Solution 3Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 2Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 3Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 4Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 5Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 6Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 7Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 8Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 9Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 10Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 11Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 12Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 13Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 14Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 15Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 16Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 17Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 18Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 19Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 20Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 21Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 22Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 23Health News:P&G Reports Fourth Quarter EPS of $0.92 and Operating Profit Growth of 13%, Behind Balanced 5% Organic Sales and Volume Growth 24Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 2Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 3Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 4Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 5Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 6Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 7Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 8Health News:CryoCath Announces Fiscal 2008 Third Quarter Results 9
(Date:1/15/2014)... 15, 2014  Humberto C. Antunes,  Galderma  worldwide CEO, will ... Journal of Drugs in Dermatology (JDD) at ... The event is January 17-20, 2014, at the Omni Orlando Resort ... The ODAC is a distinguished event that ...
(Date:1/15/2014)... Tegra Medical is very pleased to announce the appointment of ... Executive Officer.  Mark was promoted from his current role of ... four facilities in Massachusetts , ... Medical in 2012 with 20+ years of broad-based operations, sales, ...
(Date:1/15/2014)... , Jan. 15, 2014  According to Millennium ... technology market intelligence, the United States ... (TEO) device markets will expand moderately through 2022, ... segments. In particular, increasing interest in drug-eluting beads ...
Breaking Medicine Technology:Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 2Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 3Galderma's global leader honored with a "Lifetime in Dermatology Achievement Award" by Journal of Drugs in Dermatology 4Tegra Medical Appoints New Chief Executive Officer 2Tegra Medical Appoints New Chief Executive Officer 3US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
Lorenz 2.0 mm titanium system for the midface provides an excellent alternative to lower profile systems in areas of the midface where greater fixation is needed....
Lorenz 1.0 mm titanium system provides a rigid fixation alternative for areas with high palpability and prominent bone formation. These areas include the frontal bone and the areas surrounding the or...
A unique system for secure fixation of the cranial bone flap after craniotomy. Craniofix eliminates the need for mini plates, screws, and additional drills....
1.0 mm Micro System. The Titanium Micro System is also useful in the practice of ENT, Neurosurgery and Handsurgery....
Medicine Products: